Modulator therapies have the ability to improve CFTR function and mutant CFTR protein in CF patients and are classified into the following five main categories according to their respective effects on CFTR mutations: enhancers, correctors, stabilizers, read-through agents, and enhancers [9]. The gene discussed is CFTR; the disease is cystic fibrosis.